Matrix metalloproteinases as novel disease markers in Takayasu arteritis

Akifumi Matsuyama, Naohiko Sakai, Masato Ishigami, Hisatoyo Hiraoka, Susumu Kashine, Ayumu Hirata, Tadashi Nakamura, Shizuya Yamashita, Yuji Matsuzawa

Research output: Contribution to journalArticle

103 Citations (Scopus)

Abstract

Background - Takayasu arteritis (TA) is a chronic vasculitis that primarily affects large elastic arteries. Monitoring of disease activity is crucial because the disease tends to progress despite treatment with glucocorticoid and/or immunosuppressive agents. Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) have generally been used as disease activity markers, but these are nonspecific inflammatory markers and lack the sensitivity and specificity to accurately monitor the disease status. Given the histological findings characterized by destruction of elastic fibers, we hypothesized that matrix metalloproteinases (MMPs) could be useful as markers of disease activity in TA. Methods and Results - A consecutive series of 25 patients with TA were enrolled in this study. According to the National Institutes of Health criteria of disease activity, 11 were in an active phase and the remaining 14 were in remission. Circulating levels of MMP-2, MMP-3, and MMP-9 were determined by ELISA in all patients with TA and controls. MMP-2 levels were higher in patients with TA than in controls, but no correlation was found between serum MMP-2 and disease activity score. In contrast, MMP-3 and MMP-9 levels in patients with active disease were higher than in patients in remission and controls, and a positive correlation was demonstrated between circulating levels of MMP-3 or MMP-9 and disease activity score. The high levels of MMP-3 and MMP-9 improved when patients underwent remission. Conclusions - The present results indicate that MMP-2 can be helpful in diagnosing TA and that MMP-3 and MMP-9 can be used as activity markers for TA.

Original languageEnglish
Pages (from-to)1469-1473
Number of pages5
JournalCirculation
Volume108
Issue number12
DOIs
Publication statusPublished - 23-09-2003

Fingerprint

Takayasu Arteritis
Matrix Metalloproteinases
Matrix Metalloproteinase 3
Matrix Metalloproteinase 9
Matrix Metalloproteinase 2
Elastic Tissue
Blood Sedimentation
National Institutes of Health (U.S.)
Immunosuppressive Agents
Vasculitis
C-Reactive Protein
Glucocorticoids
Arteries
Enzyme-Linked Immunosorbent Assay
Sensitivity and Specificity

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Matsuyama, A., Sakai, N., Ishigami, M., Hiraoka, H., Kashine, S., Hirata, A., ... Matsuzawa, Y. (2003). Matrix metalloproteinases as novel disease markers in Takayasu arteritis. Circulation, 108(12), 1469-1473. https://doi.org/10.1161/01.CIR.0000090689.69973.B1
Matsuyama, Akifumi ; Sakai, Naohiko ; Ishigami, Masato ; Hiraoka, Hisatoyo ; Kashine, Susumu ; Hirata, Ayumu ; Nakamura, Tadashi ; Yamashita, Shizuya ; Matsuzawa, Yuji. / Matrix metalloproteinases as novel disease markers in Takayasu arteritis. In: Circulation. 2003 ; Vol. 108, No. 12. pp. 1469-1473.
@article{97237658377b4c6c815391ad185e9e64,
title = "Matrix metalloproteinases as novel disease markers in Takayasu arteritis",
abstract = "Background - Takayasu arteritis (TA) is a chronic vasculitis that primarily affects large elastic arteries. Monitoring of disease activity is crucial because the disease tends to progress despite treatment with glucocorticoid and/or immunosuppressive agents. Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) have generally been used as disease activity markers, but these are nonspecific inflammatory markers and lack the sensitivity and specificity to accurately monitor the disease status. Given the histological findings characterized by destruction of elastic fibers, we hypothesized that matrix metalloproteinases (MMPs) could be useful as markers of disease activity in TA. Methods and Results - A consecutive series of 25 patients with TA were enrolled in this study. According to the National Institutes of Health criteria of disease activity, 11 were in an active phase and the remaining 14 were in remission. Circulating levels of MMP-2, MMP-3, and MMP-9 were determined by ELISA in all patients with TA and controls. MMP-2 levels were higher in patients with TA than in controls, but no correlation was found between serum MMP-2 and disease activity score. In contrast, MMP-3 and MMP-9 levels in patients with active disease were higher than in patients in remission and controls, and a positive correlation was demonstrated between circulating levels of MMP-3 or MMP-9 and disease activity score. The high levels of MMP-3 and MMP-9 improved when patients underwent remission. Conclusions - The present results indicate that MMP-2 can be helpful in diagnosing TA and that MMP-3 and MMP-9 can be used as activity markers for TA.",
author = "Akifumi Matsuyama and Naohiko Sakai and Masato Ishigami and Hisatoyo Hiraoka and Susumu Kashine and Ayumu Hirata and Tadashi Nakamura and Shizuya Yamashita and Yuji Matsuzawa",
year = "2003",
month = "9",
day = "23",
doi = "10.1161/01.CIR.0000090689.69973.B1",
language = "English",
volume = "108",
pages = "1469--1473",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

Matsuyama, A, Sakai, N, Ishigami, M, Hiraoka, H, Kashine, S, Hirata, A, Nakamura, T, Yamashita, S & Matsuzawa, Y 2003, 'Matrix metalloproteinases as novel disease markers in Takayasu arteritis', Circulation, vol. 108, no. 12, pp. 1469-1473. https://doi.org/10.1161/01.CIR.0000090689.69973.B1

Matrix metalloproteinases as novel disease markers in Takayasu arteritis. / Matsuyama, Akifumi; Sakai, Naohiko; Ishigami, Masato; Hiraoka, Hisatoyo; Kashine, Susumu; Hirata, Ayumu; Nakamura, Tadashi; Yamashita, Shizuya; Matsuzawa, Yuji.

In: Circulation, Vol. 108, No. 12, 23.09.2003, p. 1469-1473.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Matrix metalloproteinases as novel disease markers in Takayasu arteritis

AU - Matsuyama, Akifumi

AU - Sakai, Naohiko

AU - Ishigami, Masato

AU - Hiraoka, Hisatoyo

AU - Kashine, Susumu

AU - Hirata, Ayumu

AU - Nakamura, Tadashi

AU - Yamashita, Shizuya

AU - Matsuzawa, Yuji

PY - 2003/9/23

Y1 - 2003/9/23

N2 - Background - Takayasu arteritis (TA) is a chronic vasculitis that primarily affects large elastic arteries. Monitoring of disease activity is crucial because the disease tends to progress despite treatment with glucocorticoid and/or immunosuppressive agents. Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) have generally been used as disease activity markers, but these are nonspecific inflammatory markers and lack the sensitivity and specificity to accurately monitor the disease status. Given the histological findings characterized by destruction of elastic fibers, we hypothesized that matrix metalloproteinases (MMPs) could be useful as markers of disease activity in TA. Methods and Results - A consecutive series of 25 patients with TA were enrolled in this study. According to the National Institutes of Health criteria of disease activity, 11 were in an active phase and the remaining 14 were in remission. Circulating levels of MMP-2, MMP-3, and MMP-9 were determined by ELISA in all patients with TA and controls. MMP-2 levels were higher in patients with TA than in controls, but no correlation was found between serum MMP-2 and disease activity score. In contrast, MMP-3 and MMP-9 levels in patients with active disease were higher than in patients in remission and controls, and a positive correlation was demonstrated between circulating levels of MMP-3 or MMP-9 and disease activity score. The high levels of MMP-3 and MMP-9 improved when patients underwent remission. Conclusions - The present results indicate that MMP-2 can be helpful in diagnosing TA and that MMP-3 and MMP-9 can be used as activity markers for TA.

AB - Background - Takayasu arteritis (TA) is a chronic vasculitis that primarily affects large elastic arteries. Monitoring of disease activity is crucial because the disease tends to progress despite treatment with glucocorticoid and/or immunosuppressive agents. Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) have generally been used as disease activity markers, but these are nonspecific inflammatory markers and lack the sensitivity and specificity to accurately monitor the disease status. Given the histological findings characterized by destruction of elastic fibers, we hypothesized that matrix metalloproteinases (MMPs) could be useful as markers of disease activity in TA. Methods and Results - A consecutive series of 25 patients with TA were enrolled in this study. According to the National Institutes of Health criteria of disease activity, 11 were in an active phase and the remaining 14 were in remission. Circulating levels of MMP-2, MMP-3, and MMP-9 were determined by ELISA in all patients with TA and controls. MMP-2 levels were higher in patients with TA than in controls, but no correlation was found between serum MMP-2 and disease activity score. In contrast, MMP-3 and MMP-9 levels in patients with active disease were higher than in patients in remission and controls, and a positive correlation was demonstrated between circulating levels of MMP-3 or MMP-9 and disease activity score. The high levels of MMP-3 and MMP-9 improved when patients underwent remission. Conclusions - The present results indicate that MMP-2 can be helpful in diagnosing TA and that MMP-3 and MMP-9 can be used as activity markers for TA.

UR - http://www.scopus.com/inward/record.url?scp=0141727721&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141727721&partnerID=8YFLogxK

U2 - 10.1161/01.CIR.0000090689.69973.B1

DO - 10.1161/01.CIR.0000090689.69973.B1

M3 - Article

VL - 108

SP - 1469

EP - 1473

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 12

ER -

Matsuyama A, Sakai N, Ishigami M, Hiraoka H, Kashine S, Hirata A et al. Matrix metalloproteinases as novel disease markers in Takayasu arteritis. Circulation. 2003 Sep 23;108(12):1469-1473. https://doi.org/10.1161/01.CIR.0000090689.69973.B1